Explore 3 Stock Ideas & Industry Insights Download Free Report

TelyRx Holdings Inc.

Healthcare CA TELY

2.5CAD
-0.1(3.85%)

Last update at 2026-06-03T18:11:00Z

Day Range

2.452.85
LowHigh

52 Week Range

3.004.25
LowHigh

Fundamentals

  • Previous Close 2.60
  • Market Cap170.98M
  • Volume7201
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.77900M
  • Revenue TTM33.30M
  • Revenue Per Share TTM3.17
  • Gross Profit TTM 15.62M
  • Diluted EPS TTM-0.09

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Income before tax -0.42332M -4.82900M -1.63800M
Minority interest - - -
Net income -0.42332M -13.48300M -4.39400M
Selling general administrative 0.44M 6.20M 0.46M
Selling and marketing expenses - - -
Gross profit - 3.51M 0.00200M
Reconciled depreciation - 0.20M 0.03M
Ebit - - -
Ebitda - - -
Depreciation and amortization - - -
Non operating income net other - - -
Operating income -0.43810M -3.92700M -0.74600M
Other operating expenses - - -
Interest expense - 0.93M 0.89M
Tax provision - - -
Interest income 0.01M - -
Net interest income - -0.93100M -0.89200M
Extraordinary items - - -
Non recurring - - -
Other items - - -
Income tax expense - - -
Total revenue 0.00000M 9.53M 0.03M
Total operating expenses 0.44M 13.46M 0.77M
Cost of revenue - 6.02M 0.03M
Total other income expense net - 0.03M -
Discontinued operations - - -
Net income from continuing ops - -4.82900M -1.63800M
Net income applicable to common shares -0.42332M - -
Preferred stock and other adjustments - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Total assets 1.51M 7.95M 11.90M
Intangible assets - 0.64M 0.29M
Earning assets - - -
Other current assets - - -
Total liab 0.06M 10.99M 13.54M
Total stockholder equity 1.45M -3.04600M -1.63900M
Deferred long term liab - - -
Other current liab - - 5.73M
Common stock 1.57M - -
Capital stock - 15.91M 3.84M
Retained earnings -0.42332M -18.96100M -5.47800M
Other liab - - -
Good will - - -
Other assets - - -
Cash 1.51M 3.31M 0.23M
Cash and equivalents - - -
Total current liabilities 0.06M 1.55M 6.97M
Current deferred revenue - - -
Net debt - 3.90M 5.33M
Short term debt 0.00000M - -
Short long term debt - - 0.06M
Short long term debt total - - -
Other stockholder equity 0.31M - -
Property plant equipment - - -
Total current assets 1.51M 4.77M 10.47M
Long term investments - - -
Net tangible assets - - -
Short term investments - - -
Net receivables - 0.38M 0.00200M
Long term debt - 7.21M 5.50M
Inventory - 0.46M 0.06M
Accounts payable - 0.94M 0.11M
Total permanent equity - - -
Noncontrolling interest in consolidated entity - - -
Temporary equity redeemable noncontrolling interests - - -
Accumulated other comprehensive income - - -
Additional paid in capital - - -
Common stock total equity - - -
Preferred stock total equity - - -
Retained earnings total equity - - -
Treasury stock - - -
Accumulated amortization - - -
Non currrent assets other - - -
Deferred long term asset charges - - -
Non current assets total - 3.18M 1.44M
Capital lease obligations - 2.32M 1.13M
Long term debt total 0.00000M - -
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Investments - -0.44000M 0.00000M
Change to liabilities - - -
Total cashflows from investing activities - - -
Net borrowings - 0.73M 0.06M
Total cash from financing activities 1.62M 7.28M 0.35M
Change to operating activities - - -
Net income -0.42332M -13.48300M -4.39400M
Change in cash 1.51M 2.88M -2.56500M
Begin period cash flow 3.31M 0.44M 3.00M
End period cash flow - 3.31M 0.44M
Total cash from operating activities -0.10914M -2.91900M -2.46900M
Issuance of capital stock - 6.55M 0.29M
Depreciation - 0.20M 0.03M
Other cashflows from investing activities - - -
Dividends paid - - -
Change to inventory - -0.39900M -0.06100M
Change to account receivables - -0.37800M -0.00100M
Sale purchase of stock 1.62M - -
Other cashflows from financing activities - - -
Change to netincome - - -
Capital expenditures 0.00000M 0.74M 0.36M
Change receivables - - -
Cash flows other operating - - -
Exchange rate changes - - -
Cash and cash equivalents changes - - -
Change in working capital 0.06M 0.21M -0.30200M
Stock based compensation - 3.20M 0.00000M
Other non cash items - 0.99M 0.95M
Free cash flow - -3.65800M -2.82800M

Peer Comparison

Sector: Healthcare Industry: Pharmaceutical Retailers

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
TELY
TelyRx Holdings Inc.
-0.1 3.85% 2.50 - - 5.14 - 2.27

Reports Covered

Stock Research & News

Profile

TelyRx Holdings Inc. operates as a vertically integrated technology-enabled healthcare and pharmacy services company which develops and operates a digital pharmacy platform. Its platform connects patients nationwide with physicians for access to everyday prescriptions. The company also operates pharmacies which ship the medicine to the patient's door with next-day delivery. It caters to doctors, veterinarians, practice groups, and other licensed prescribers. The company was founded in 2022 and is based in Clearwater, Florida.

TelyRx Holdings Inc.

24761 US Hwy 19N, Clearwater, FL, United States, 33763

Key Executives

Name Title Year Born
Ms. Vanessa Slowey President, CEO & Director 1969
Mr. Adam Gardner Chief Operating Officer NA
Mr. John Eustice Secretary & General Counsel NA
Mr. Peter Lloyd Chief Revenue Officer NA
Mr. Rafael Jose Chief Digital Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.